Patent & IP news for November 23, 2015

Patent Litigations

USPTO Weekly Stats

7,483
published
appl'ns
6,774
granted
patents
64
ptab
decisions

Patent & IP Blogs

post image When words mean what they say: Bob Marley copyrights stay where they are from ipkitten.blogspot.com

Not so exciting ... BSI Enterprises Ltd & Another v Blue Mountain Music Ltd [2015] EWCA Civ 1151, a Court of Appeal, England and Wales, ruling of 18 November 2015, is one of those decisions that looks ...

Share via E–mail | Twitter | Facebook

post image Mock trial under UPC 18th draft Rules: this will take some pluck ... from patlit.blogspot.com

EPLIT, the European Patent Litigation Association, is running a mock trial under the recently-published 18th draft of the Rules of Procedures for the Unified Patent Court. The details look like this:
On 22 January 2016 ...

Share via E–mail | Twitter | Facebook

post image Monday miscellany from ipkitten.blogspot.com

In "Jumpin' through hoops? A copyright claim that never got off the ground", this Kat hosted a guest contribution from Kevin Winters on a copyright infringement action brought by Jacobus Rentmeester against Nike on the ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

November 20, 2015 - 2015 Friedman Memorial Lecture on Excellence in Appellate Advocacy (Federal Circuit Bar Association) - Washington, DC November 23, 2015 - "Double Patenting: Defeating Double Patenting Rejections and Avoiding Terminal Disclaimers" (Strafford) - 1:00 to ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Merck Sharp & Dohme Corp. v. Savior Lifetec Corp. 5:15-cv-00415; filed August 21, 2015 in the ...

Share via E–mail | Twitter | Facebook

Is The Internet Of Things (IoT) Really New Or Simply Recycled? from www.ip-watch.org

There is a lot of hype around the Internet of Things (IoT) yet many, if not most, are confused by what IoT really is and what it means for their IP and their business. In ...

Share via E–mail | Twitter | Facebook

WTO Committee Agrees To Keep IP From Non-Violation Complaints Until 2017 from www.ip-watch.org

Today, the World Trade Organisation intellectual property committee agreed on a recommendation to extend until 2017 a moratorium shielding intellectual property from a mechanism through which one WTO member can go after another member even ...

Share via E–mail | Twitter | Facebook

Ignoring Patent Demand Letters from patentlyo.com

by Dennis Crouch Professor Colleen Chien has published an unfortunate new Wall Street Journal essay titled “The Best Way to Fight a Patent Demand May Be to Do Nothing.”  Chien’s factual bases appears spot-on ...

Share via E–mail | Twitter | Facebook

In-Store Discount Patents Not Invalid Under 35 U.S.C. § 101 Prior to Claim Construction from docketreport.blogspot.com

The magistrate judge recommended denying without prejudice defendants' motion for judgment on the pleadings that plaintiff's in-store discount patents were invalid for lack of patentable subject matter because defendants did not establish, prior to ...

Share via E–mail | Twitter | Facebook

Merck KGaA buys SigmaAldrich from ipbiz.blogspot.com


IPBiz notes the completion of the purchase of SigmaAldrich by MerckKGaA, the German company, which company is distinct from the company known as Merck in the United States:


Sigma-Aldrich will be combined into Merck KGaA ...

Share via E–mail | Twitter | Facebook

Colleen Chien on "doing nothing" from ipbiz.blogspot.com


Before IPBiz could write a response to Colleen Chien's post The Best Way to Fight a Patent Demand May Be to Do Nothing, PatentlyO had already criticized the Chien work.

The Chien post begins ...

Share via E–mail | Twitter | Facebook

Medicines Patent Pool: First Licence Agreement For Hepatitis C Drug from www.ip-watch.org

The Medicines Patent Pool announced today that it signed a first licence for a hepatitis C drug with Bristol-Myers Squibb. The agreement allows manufacturing of daclatasvir, royalty-free in 112 low-and middle-income countries.

Share via E–mail | Twitter | Facebook

Never Too Late: if you missed the IPKat last week ... from ipkitten.blogspot.com

Last week was another phenomenally busy one for the IPKat blogging team, a week in which we received over 60,000 casual visitors and a whole hatful of new email subscribers.  To help you help ...

Share via E–mail | Twitter | Facebook

US, China Talk Standards & IP, Trade Secrets, GIs, Broadcasting, Enforcement from www.ip-watch.org

The 26th United States-China Joint Commission on Commerce and Trade (JCCT) meeting was held from 21-23 November, and covered a wide range of intellectual property-related areas, including standards and IP, trade secrets, geographical indications, sports ...

Share via E–mail | Twitter | Facebook

Notes from the PPAC Meetings from patentlyo.com

Global Dossier has now been released (November 2015). USPTO Collected over $3 billion in user fees in FY2015. That figure was below budget. Spending limit is around $3.5 billion, but is limited by revenue ...

Share via E–mail | Twitter | Facebook

"Software" Claims Reciting No Structural Components and Having Questionable Novelty Struck Down under 35 U.S.C. § 101 from www.patentdocs.org

By Joseph Herndon -- Two recent District Court decisions show examples of "weak" claims, which in the past would likely be found invalid as lacking novelty or being obvious, but today are struck down as being ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2015 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.